Health Condition 1: C509- Malignant neoplasm of breast of unspecified site Health Condition 2: C509- Malignant neoplasm of breast of unspecified site
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Subjects diagnosed with breast cancer and having signs and symptoms of febrile neutropenia. 2. Patients of either sex aged between 20-70 years who have refused for chemotherapy and radio therapy and who have dropped from chemotherapy and radio therapy due to febrile neutropenia 3. Patients fit for oral administration of drugs. 4. Patients who have signed the informed consent form. 5. Patients developing febrile neutropenia with ANC- 500- 1500cells/mcl 6. Patients with HB% above 6 gms%-11gm% 7. Patients with WBC count above 2000 cells/ mcl 8. Patients with RBC count above 2 million cells/ mcl 9. Patients with platelet count above 50,000cells/ mcl 10. Patients with temperature above 1000F and below 1050F.
Exclusion criteria
Exclusion criteria: 1. Patients who are unconscious, or in stage of coma, MODS. 2. Patients with Oncological emergencies, leukemia, bleeding tumors etc. 3. Absolute neutrophil count 4. Patients who have not signed informed consent form.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) Increase nuetrophill count 2) Bring down fever ( body temperature) 3) Relief from symptomsTimepoint: 55 Days | — |
Secondary
| Measure | Time frame |
|---|---|
| Increase the quality of life and continue the all chemotherapy cycles without any dropoutsTimepoint: 55 DAYS | — |
Countries
India
Contacts
TGAMC and hospital Bellary